Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. (NTLA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NTLA · as of Jun 8, 2026
Key Statistics
Explore Intellia Therapeutics, Inc. Data
ntla stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 39 · Buy rate: 71.8%
The NTLA analyst consensus is Buy, based on ratings from 39 Wall Street analysts over the past 3 months. The average 12-month price target is $26.29, representing +94.17% upside from the current price of $13.54.
Competitors & Peers
ntla competitorsNTLA
BCRX
BHVN
IMNM
PHVS
STOKStock Performance
Full HistoryAbout Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatmen…
what is intellia therapeutics, inc. · ntla stock overview · intellia therapeutics, inc. company profile · who is intellia therapeutics, inc. ceo · ntla NASDAQ · intellia therapeutics, inc. headquarters · intellia therapeutics, inc. business segments
About Stock Overview & Key Data
Intellia Therapeutics, Inc. (NTLA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 6, 2016. As of the latest trading session, NTLA stock price is $13.54, with a market capitalization of $1.5B. The stock has returned +63.53% over the past 12 months and +50.61% year-to-date.
According to 39 Wall Street analysts, the consensus rating for Intellia Therapeutics, Inc. stock is Buy, with an average 12-month price target of $26.29. In fiscal year 2025, Intellia Therapeutics, Inc. reported revenue of $67.7M and net income of -$412.7M. For detailed data — including Intellia Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Intellia Therapeutics, Inc. (NTLA) stock price is $13.54. The stock is traded on NASDAQ under the ticker symbol NTLA. The 52-week range is $7.31 – $28.25.